meglumine antimoniate has been researched along with malondialdehyde in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Serarslan, G; Söğüt, S; Yilmaz, HR | 1 |
| Alves, MP; Daher, EF; Henn, GA; Martins, AM; Meneses, GC; Montenegro, BL; Oliveira, MJ; Rocha, HA; Sampaio, AM; Silva, GB | 1 |
| Bahrami, S; Bemani, E; Oryan, A | 1 |
3 other study(ies) available for meglumine antimoniate and malondialdehyde
| Article | Year |
|---|---|
Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antioxidants; Antiprotozoal Agents; Child; Child, Preschool; Female; Glutathione Peroxidase; Humans; Leishmaniasis, Cutaneous; Lipid Peroxidation; Male; Malondialdehyde; Meglumine; Meglumine Antimoniate; Middle Aged; Nitric Oxide; Organometallic Compounds; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species; Superoxide Dismutase | 2005 |
Preliminary study on tubuloglomerular dysfunction and evidence of renal inflammation in patients with visceral leishmaniasis.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Biomarkers; Case-Control Studies; Chemokine CCL2; Female; Humans; Inflammation; Kidney; Kidney Diseases; Leishmaniasis, Visceral; Male; Malondialdehyde; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult | 2014 |
Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major.
Topics: Adiponectin; Amiodarone; Animals; Anti-Arrhythmia Agents; Antiprotozoal Agents; Cell Line; Female; Glutathione Peroxidase; Inhibitory Concentration 50; Interleukin-6; Leishmania major; Leishmaniasis, Cutaneous; Lymph Nodes; Macrophages; Malondialdehyde; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Parasite Load; Random Allocation; Skin; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2019 |